Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Operating Expenses | 10,106 | 9,470 | 8,812 | 7,695 | 8,181 |
| Operating Income | -10,106 | -9,470 | -8,812 | -7,695 | -8,181 |
| Interest Expense | 1,068 | -12,681 | 35 | 48 | 14,367 |
| Other Income | 2,423 | -8,025 | 4,340 | 7,177 | 223 |
| Pre-tax Income | -8,752 | -4,814 | -4,507 | -566 | -22,325 |
| Income Tax | -1,710 | -1,652 | -1,458 | -1,398 | -1,141 |
| Net Income Continuous | -7,041 | -3,162 | -3,049 | 832 | -21,184 |
| Net Income | $-7,041 | $-3,162 | $-3,049 | $832 | $-21,184 |
| EPS Basic Total Ops | -0.53 | -0.25 | -0.23 | 0.06 | -1.60 |
| EPS Basic Continuous Ops | -0.53 | -0.24 | -0.23 | 0.06 | -1.61 |
| EPS Diluted Total Ops | -0.53 | -0.25 | -0.23 | 0.06 | -1.60 |
| EPS Diluted Continuous Ops | -0.53 | -0.24 | -0.23 | 0.06 | -1.61 |
| EBITDA(a) | $-9,973 | $-9,433 | $-8,782 | $-7,663 | $-8,149 |